The data has been generated from an online webbased database of competences, supported through an EU specific support action.The project has been implemented by AVEDAS AG, Germany, Karolinska Institutet, Sweden and EuropaBio, Belgium.
It contains all the health related projects funded by the EU during the last Research Framework Programme, as well as the principal organisations participating in these projects. The aim of this database is to increase transparency and accessibility of research competences in Europe, both for Europeans (in a recent Eurobarometer, 70% of them expressed their interest in health research) but also for other nationalities interested in participating in the European Health Research effort.
In the European Research Programme going from 2001 to 2006 (FP6), the part of the programme focussing on health research was major with its budget of € 2.4 billion supporting 680 projects. It was shared between different research areas with about 50% of the projects and budget dedicated to disease oriented research areas. Cancer is the area receiving most support with 123 projects, about 18 % of projects partly or entirely focussed on cancer, with 22 % of the budget (€ 539 million). Other important research areas are AIDS/HIV, Stem Cell Research, Diabetes, Diagnostics, Vaccines and Drug design.
An important policy in the EU is to support competitiveness by encouraging cooperation of academia and clinicians with industry, and especially with small and medium-sized enterprises (SMEs). Out of 2.438 unique partners in health research projects, 853 are from the private sector, of which 365 SMEs (15%). It means that around 20 % of the total number of SMEs in the Health sector are participating in the EU programme. The majority of partners in the programme are academic.
Another important policy in European research is international cooperation. Participation from countries outside Europe and its associated states represents about 5% of partners of health projects. The highest number of participations are from China, Russia, US and South Africa. Within Europe, about 6% of the partners are from the 12 new EU-member states and 7% of the partners are from the states associated to the EU with science and technology cooperation agreements that involved contributing to the framework programme budget.
It is expected that the 'LifeCompetence' database will have many positive implications for the Health research society in Europe and for worldwide cooperations, e.g. increased knowledge transfer, better partnerships and more efficient management of research programmes and research organisations, as well as providing a transparent information on the resources invested in funding health research at the European level.
Oink, oink makes the pig - Pictures and gestures are effective support methods in foreign language teaching for children
13.05.2020 | Technische Universität Dresden
How Humans and Machines Navigate Complex Situations
19.11.2018 | Max-Planck-Institut für Bildungsforschung
In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria.
Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding...
An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...
Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.
Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
04.06.2020 | Life Sciences
04.06.2020 | Physics and Astronomy
04.06.2020 | Life Sciences